GLAUKOS Corp Capital Expenditures Incurred but Not yet Paid
GLAUKOS Corp (GKOS) reported Capital Expenditures Incurred but Not yet Paid of $703.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-29
- GLAUKOS Corp capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$160.00K, a 281.82% decline year-over-year.
- GLAUKOS Corp capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $863.00K, a 71.91% increase year-over-year.
- GLAUKOS Corp capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $2.08M, a 161.89% increase year-over-year.
- GLAUKOS Corp capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $248.00K.
- GLAUKOS Corp capital expenditures incurred but not yet paid for fiscal 2025 was $2.92M, a 221.23% increase from fiscal 2024.
- GLAUKOS Corp capital expenditures incurred but not yet paid for fiscal 2024 was $909.00K, a 31.81% decline from fiscal 2023.
- GLAUKOS Corp capital expenditures incurred but not yet paid for fiscal 2023 was $1.33M, a 64.89% decline from fiscal 2022.
- GLAUKOS Corp capital expenditures incurred but not yet paid for fiscal 2022 was $3.80M, a 67.79% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $703.00K 10-Q · filed 2026-07-29 | $2.79M derived: sum of 3 quarters · filed 2026-07-29 | $3.03M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $863.00K 10-Q · filed 2026-04-30 | $2.94M derived: sum of 2 quarters · filed 2026-04-30 | $3.19M derived: sum of 3 quarters · filed 2026-04-30 | $3.28M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.33M derived: sum of 2 quarters · filed 2026-02-23 | $2.42M derived: sum of 3 quarters · filed 2026-07-29 | $2.92M 10-K · filed 2026-02-23 |
| 2025-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $336.00K derived: sum of 2 quarters · filed 2026-07-29 | $838.00K 10-Q · filed 2025-10-31 | $1.63M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $590.00K 10-Q · filed 2026-07-29 | $1.39M derived: sum of 3 quarters · filed 2026-07-29 | $987.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $502.00K 10-Q · filed 2026-04-30 | $1.30M derived: sum of 2 quarters · filed 2026-04-30 | $899.00K derived: sum of 3 quarters · filed 2026-04-30 | -$164.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $397.00K derived: sum of 2 quarters · filed 2026-02-23 | -$666.00K derived: sum of 3 quarters · filed 2026-02-23 | $909.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | -$398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | -$1.46M derived: sum of 2 quarters · filed 2025-10-31 | $114.00K 10-Q · filed 2025-10-31 | -$1.75M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $512.00K 10-Q · filed 2025-08-04 | -$1.36M derived: sum of 3 quarters · filed 2026-02-23 | -$1.24M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $1.57M 10-Q · filed 2025-05-01 | -$293.00K derived: sum of 2 quarters · filed 2026-02-23 | -$172.00K derived: sum of 3 quarters · filed 2026-02-23 | $487.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.75M derived: sum of 2 quarters · filed 2026-02-23 | -$1.09M derived: sum of 3 quarters · filed 2026-02-23 | $1.33M 10-K · filed 2026-02-23 |
| 2023-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $780.00K derived: sum of 2 quarters · filed 2024-11-05 | $3.20M 10-Q · filed 2024-11-05 | $3.74M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $3.08M 10-Q · filed 2024-08-02 | $3.62M derived: sum of 3 quarters · filed 2025-02-25 | $3.57M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.42M 10-Q · filed 2024-05-03 | $2.96M derived: sum of 2 quarters · filed 2025-02-25 | $2.91M derived: sum of 3 quarters · filed 2025-02-25 | $3.51M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $487.00K derived: sum of 2 quarters · filed 2025-02-25 | $1.09M derived: sum of 3 quarters · filed 2025-02-25 | $3.80M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $553.00K derived: sum of 2 quarters · filed 2023-11-01 | $3.26M 10-Q · filed 2023-11-01 | $3.28M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $3.31M 10-Q · filed 2023-08-02 | $3.33M derived: sum of 3 quarters · filed 2024-02-23 | $955.00K derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $2.71M 10-Q · filed 2023-05-04 | $2.72M derived: sum of 2 quarters · filed 2024-02-23 | $350.00K derived: sum of 3 quarters · filed 2024-02-23 | $1.12M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$2.35M derived: sum of 2 quarters · filed 2024-02-23 | -$1.58M derived: sum of 3 quarters · filed 2024-02-23 | $2.26M 10-K · filed 2024-02-23 |
| 2021-09-30 | -$2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$1.60M derived: sum of 2 quarters · filed 2022-11-04 | $2.24M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $770.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.62M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $3.85M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $641.00K 10-K · filed 2023-02-24 | |||
| 2019-12-31 | $995.00K 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $152.00K 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $749.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |